SUNNYVALE, Calif., Aug. 31, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the launch of Accuray Exchange in Radiation Oncology (AERO), a global organization for CyberKnife® Robotic Radiosurgery System and TomoTherapy® Radiation Therapy System users dedicated to advancing patient care through worldwide clinical and technical collaboration.
AERO's mission is to provide a global forum for the clinical exchange of information between clinicians and physicists for the purpose of setting a new standard in patient care and safety across treatments in the fields of SRS/SBRT, IMRT and conventional radiation therapy. The organization will be led and co-directed by a board of clinicians and physicists from around the world and will be administratively managed within Accuray's Medical Affairs group. The organization will consist of four regional chapters - Americas, Asia-Pacific, EIMEA and Japan, each with its own board of luminary leaders. Within AERO will be two main divisions, one for the fields of SRS and SBRT and one for the fields of IMRT and extended/conventionally fractionated radiation therapy. Membership to AERO is free and open to all users of the CyberKnife and TomoTherapy Systems who are eligible as defined by membership requirements.
Members of AERO will gain access to global and region-specific online communities for the exchange of clinical and technical information, as well as updates on peer-reviewed publications, tailored training and continuing education opportunities focused on patient care.
Prof. Eric Lartigau, MD, PhD, head of academic radiotherapy, Centre Oscar Lambret, Lille, France, will serve as the global President of AERO. Prof. Lartigau is an experienced user of